Product Name:2-(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)ethan-1-amine hydrochloride
IUPAC Name:2-(2,3-dihydro-1,4-benzodioxin-2-yl)ethan-1-amine hydrochloride
| Packing Unit | Available Stock | Price($) | Quantity |
|---|---|---|---|
| CM124544-1g | in stock | ȷȌȷ |
|
|
|||
| Product Overview |
2-(2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)ethanamine hydrochloride, commonly known as DBED, is a chemical compound that has gained significant attention in the scientific community due to its potential therapeutic applications. DBED is a synthetic compound that belongs to the family of phenethylamines and is structurally similar to the neurotransmitter serotonin. |
| Synthesis Method |
The synthesis of DBED involves the reaction of 2,3-dihydrobenzo[b][1,4]dioxine with ethylenediamine in the presence of hydrochloric acid. The reaction yields DBED as a hydrochloride salt, which is a white crystalline powder. The purity of DBED can be increased by recrystallization from ethanol. |
| Synthesis and Application |
DBED has been extensively studied for its potential therapeutic applications. It has been shown to have a high affinity for the serotonin transporter, which makes it a potential candidate for the treatment of depression and anxiety disorders. DBED has also been shown to have neuroprotective properties, which makes it a potential candidate for the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's disease. |
| Future Directions |
One direction is to conduct clinical trials to determine its safety and efficacy for the treatment of depression, anxiety disorders, and neurodegenerative diseases. Another direction is to study the mechanism of action of DBED in more detail to understand how it interacts with the serotonin transporter and the 5-HT1A receptor. Additionally, the synthesis of DBED derivatives with improved pharmacological properties should be explored. |
Search 
+86 21 5895 0110 
